Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Drug Approval Trends Don't Extend to CMOs

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.
Jul 10, 2013

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.

Drug Approval Trends Don't Extend to CMOs

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.
Jun 2, 2013

Approvals of new drugs are on an upward swing, but only a few CMOs are benefiting.

Strategic Partnering for Manufacturing

Eisai and Biogen Idec pursue an innovative approach to capacity management.
May 3, 2013

Eisai and Biogen Idec pursue an innovative approach to capacity management.

Strategic Partnering for Manufacturing

Eisai and Biogen Idec pursue an innovative approach to capacity management.
Apr 2, 2013

Eisai and Biogen Idec pursue an innovative approach to capacity management.

End of the Dedicated CMO?

Is the contract-only CMO an endangered species?
Mar 6, 2013

Is the contract-only CMO an endangered species?

End of the Dedicated CMO?

Is the contract-only CMO an endangered species?
Feb 2, 2013

Is the contract-only CMO an endangered species?

The State of Outsourcing Partnerships

Preferred-provider relationships are transforming the bio/pharmaceutical industry.
Feb 1, 2013

Preferred-provider relationships are transforming the bio/pharmaceutical industry.

Acquisitions Reshape the Bio/Pharm Services Industry

The quest to build critical mass and broaden capabilities has been a key factor in dealmaking.
Jan 9, 2013

The quest to build critical mass and broaden capabilities has been a key factor in dealmaking.

Acquisitions Reshape the Bio/Pharm Services Industry

The quest to build critical mass and broaden capabilities has been a key factor in deal-making.
Dec 2, 2012

The quest to build critical mass and broaden capabilities has been a key factor in deal-making.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
9%
All of the above.
45%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here